Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$11.9K Hold
100
0.01% 219
2024
Q1
$10.7K Hold
100
0.01% 228
2023
Q4
$9.95K Hold
100
0.01% 228
2023
Q3
$10.3K Sell
100
-500
-83% -$55.8K 0.01% 240
2023
Q2
$72.9K Buy
600
+500
+500% +$66.7K 0.07% 145
2023
Q1
$15.4K Hold
100
0.01% 227
2022
Q4
$18K Hold
100
0.02% 203
2022
Q3
$12K Hold
100
0.01% 255
2022
Q2
$14K Hold
100
0.01% 253
2022
Q1
$17K Hold
100
0.02% 251
2021
Q4
$25K Sell
100
-650
-87% -$190K 0.02% 234
2021
Q3
$289K Sell
750
-50
-6% -$18.4K 0.26% 77
2021
Q2
$188K Buy
+800
New +$143K 0.16% 101

Other funds holding MRNA

EMFO LLC's MRNA Position: Q2 2024 in Review

EMFO LLC held its Moderna (MRNA) position steady in Q2 2024 at 100 shares worth $11.9K. The position accounts for 0.01% of the portfolio, ranked #219.

EMFO LLC first reported a position in MRNA in Q2 2021 and has held it in 13 quarters since. The position peaked at $289K in Q3 2021. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • EMFO LLC held 100 shares of Moderna worth $11.9K as of Q2 2024.
  • EMFO LLC left its Moderna share count unchanged in Q2 2024.
  • Moderna made up 0.01% of EMFO LLC's portfolio in Q2 2024, its #219 holding.
  • EMFO LLC first reported a position in Moderna in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Moderna position peaked at $289K in Q3 2021.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.